首页> 外文期刊>European urology >Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy

【24h】

Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy

机译：作者的回复：Ronald C. Chen。关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？ Eur Urol 2016; 69：211-2接受或不接受短期雄激素剥夺疗法的放射治疗的中危险前列腺癌患者的有利和不利结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2016年第2期|共3页
作者
Voog Justin C.; Paulus Rebecca; Efstathiou Jason A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy [J] . Voog Justin C., Paulus Rebecca, Efstathiou Jason A. European urology . 2016,第2期

机译：作者的回复：Ronald C. Chen。关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？ Eur Urol 2016; 69：211-2接受或不接受短期雄激素剥夺疗法的放射治疗的中危险前列腺癌患者的有利和不利结果
2. Reply to Yu- Wen Hu's Letter to the Editor re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7 [J] . Jacksona William C., Schipper Matthew J., Feng Felix Y. European urology . 2016,第6期

机译：回复Yu-Wen Hu的信Re：William C. Jackson，Matthew J. Schipper，Skyler B. Johnson等人。雄激素剥夺治疗的持续时间对接受自由基前列腺切除术接受放射治疗的患者的结果影响结果。 EUR UROL 2016; 69：50-7
3. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? [J] . Chen Ronald C. European urology . 2016,第2期

机译：关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Outcomes for Favorable and Unfavorable Intermediate Risk Prostate CancerPatients Receiving Radiation Therapy With or Without Short-term Androgen DeprivationTherapy [O] . Justin C. Voog, Rebecca Paulus, Jason A. Efstathiou -1

机译：有利和不利的中危前列腺癌的疗效接受或不接受短期雄激素剥夺的放射治疗患者治疗
7. Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer [O] . Rafael Gadia, MD, Elton Trigo Teixeira Leite, MD, Ana Luiza Bierrenbach, PhD, 2016

机译：对于中度和高危前列腺癌患者，单独使用剂量递增强度调制放射治疗而不使用雄激素剥夺疗法的长期结果

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号